24 May 2013
Keywords: Canada, Innovation policies, Rx&D, Intellectual property, Regulatory review, Tax credit, R&D funding
Article | 21 February 2011
In a submission to the federal government last Friday, Canada’s innovative pharmaceutical industry outlined concrete measures aimed at ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.